Nexalin Technology Inc. (NXL)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.93M
Last updated: Nov 17, 2026 at 4:30 PM ET
Nexalin Technology Inc. (NXL) Statistics
Nexalin Technology (NXL) has a market cap of $1.93M and an enterprise value of $2.09M. Its share count is up 3832.21% from a year earlier. It kept -3380.59% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 8.28% above the market cap, as debt exceeds cash.
| Market Cap | $1.93M |
|---|---|
| Enterprise Value | $2.09M |
| Latest price (Nov 17, 2026) | $1.51 |
Key Dates
The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 4.2x and 4.5x. Its year-end P/S ranged from 36.7x to 253.0x from 2022 to 2024.
| P/S Ratio | 4.2x |
|---|---|
| Forward P/S | 10.0x |
| P/B Ratio | 4.5x |
Price Statistics
The stock is down 95.34% over 52 weeks and trades 52.81% below its 50-day average.
| Beta (1Y) | 0.51 |
|---|---|
| 52-Week Change | -95.34% |
| 1-Month Change | -36.02% |
| 3-Month Change | -84.75% |
| 6-Month Change | -84.32% |
| Total Return (1Y) | -95.34% |
| Total Return (3Y CAGR) | -45.08% |
| Return vs SPY (1Y) | -106.81% |
| Max Drawdown (1Y) | -95.72% |
| Max Drawdown (3Y) | -98.93% |
| Sharpe Ratio (1Y) | -2.50 |
| Correlation with SPY (1Y) | 0.06 |
| 50-Day Average | $3.20 |
| 200-Day Average | $9.88 |
| 52-Week Range | $1.31 to $33.60 |
| RSI (14 Days) | 31.8 |
| Average Volume (20 Days) | 28.30K |
Financial Position
Current assets cover 0.69x current liabilities, and total debt is 3.62x shareholder equity.
| Current Ratio | 0.69x |
|---|---|
| Quick Ratio | 0.61x |
| Debt / Equity | 3.62x |
| Interest Coverage | -178.82x |
Returns and Efficiency
Return on invested capital is -609.24% over the last 12 months, against a 5-year average of 123.85%.
| Return on Equity (ROE) | -3559.87% |
|---|---|
| Return on Assets (ROA) | -285.18% |
| Return on Invested Capital (ROIC) | -609.24% |
| ROIC (5Y Average) | 123.85% |
| Asset Turnover | 0.07x |
| Inventory Turnover | 0.22x |
| Receivables Turnover | 3.24x |
| Cash Conversion Cycle | -1533 days |
Scores
NXL has an Altman Z-Score of -51.95, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -51.95 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $277.31K over the last 12 months is up 76.71% from the 12 months before.
| Revenue | $277.31K |
|---|---|
| Revenue Growth (YoY) | +76.71% |
| Gross Profit | $228.58K |
| Operating Income | -$9.39M |
| Pretax Income | -$9.37M |
| Net Income | -$9.37M |
| EBITDA | -$9.25M |
| Reported EPS (TTM) | -$3.78 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 8.00% of the $3.29M in total assets.
| Cash and Equivalents | $793.14K |
|---|---|
| Total Debt | $952.81K |
| Net Debt | $159.67K |
| Net Debt Per Share | $0.21 |
| Working Capital | -$869.15K |
| Shareholder Equity | $263.34K |
| Book Value Per Share | $0.34 |
| Tangible Book Value | -$819.63K |
| Total Assets | $3.29M |
| Total Liabilities | $3.02M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$6.25M |
|---|---|
| FCF Per Share | -$5.51 |
| Depreciation and Amortization | $129.75K |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -3386.02%.
| Gross Margin | 82.43% |
|---|---|
| Operating Margin | -3386.02% |
| Pretax Margin | -3380.59% |
| Net Margin | -3380.59% |
| EBITDA Margin | -3335.32% |
| Gross Margin (5Y Average) | 78.48% |
Growth
Revenue fell 38.88% a year over 3 years.
| Revenue Growth (3Y CAGR) | -38.88% |
|---|---|
| Revenue Growth (5Y CAGR) | +4.43% |
| Book Value Per Share Growth (2Y CAGR) | -31.68% |
| Tangible Book Per Share Growth (2Y CAGR) | -33.72% |
Dividends and Yields
NXL does not pay a dividend.
| Buyback Yield | -130.59% |
|---|---|
| Shareholder Yield | -130.59% |
Stock Splits
The last split was a 1-for-30 reverse split on Aug 31, 2026.
| Last Split Date | Aug 31, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:30 |
Peer Position
Against 7 similar companies, NXL has the highest P/S.
P/S RatioPeer median 0.6x
ROICPeer median -147.05%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +27.56%
| P/S Ratio | 4.2x vs 0.6x median |
|---|---|
| ROIC | -609.24% vs -147.05% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +76.71% vs +27.56% median |
Analyst Forecast
Consensus estimates put revenue growth at 5.85% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +5.85% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NXL
What is NXL's market cap?
Nexalin Technology has a market cap of $1.93M. Its enterprise value, which adds debt and subtracts cash, is $2.09M.
How many shares of NXL are outstanding?
Nexalin Technology has 776.66K shares outstanding. The count is up 3832.21% from a year earlier.
Does NXL pay a dividend?
No. Nexalin Technology does not pay a dividend.
How much debt does NXL have?
Nexalin Technology has $952.81K of total debt and $793.14K of cash and equivalents, a net debt position of $159.67K.
NXL pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors